局部麻醉与全身麻醉在破裂性腹主动脉瘤腔内修复术中的荟萃分析
该荟萃分析纳入8项队列研究,比较局部麻醉与全身麻醉下急诊破裂性腹主动脉瘤腔内修复术(REVAR)的围手术期死亡率。结果显示局部麻醉组30天/住院死亡率低于全身麻醉组(16.4% vs 25.4%;未调整OR 0.47,95%CI 0.32-0.68),调整后OR为0.37(95%CI 0.19-0.75)。但因可能存在观察偏倚,需随机对照试验验证。
要点
- 局部麻醉下REVAR与更低的30天/住院死亡率相关。
- 未调整OR为0.47,调整后OR为0.37,趋势一致。
- 结论需随机对照试验验证,因纳入研究可能存在观察偏倚。
核心结论
- 局部麻醉下REVAR的30天/住院死亡率低于全身麻醉下REVAR。
- 因纳入研究可能存在观察偏倚,需进一步随机对照试验验证。
研究设计与样本
- 遵循PRISMA指南的荟萃分析,检索多个电子数据库至2020年1月。
- 纳入报告30天/住院死亡率或多变量调整OR/HR的队列研究,比较局部麻醉与全身麻醉下急诊REVAR。
- 共纳入8项研究;第一项荟萃分析纳入7项研究共3116例患者(局部麻醉组867例,全身麻醉组2249例)。
主要发现
- 局部麻醉组30天/住院死亡率为16.4%,全身麻醉组为25.4%(未调整OR 0.47;95%CI 0.32-0.68)。
- 第二项荟萃分析中局部麻醉组30天/住院死亡率更低(未调整OR 0.55;95%CI 0.42-0.71)。
- 第三项荟萃分析显示调整后OR为0.37(95%CI 0.19-0.75),趋势相似。
关键数值与推荐
- 局部麻醉组30天/住院死亡率16.4% vs 全身麻醉组25.4%(未调整OR 0.47;95%CI 0.32-0.68)。
- 第二项荟萃分析未调整OR 0.55(95%CI 0.42-0.71)。
- 第三项荟萃分析调整后OR 0.37(95%CI 0.19-0.75)。
临床怎么用
- 对于急诊REVAR患者,优先考虑局部麻醉可能降低30天/住院死亡率。
- 临床决策需结合患者个体情况和团队经验,并注意观察偏倚可能。
局限性
- 纳入研究可能存在观察偏倚。
- 需进一步随机对照试验验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conduct a meta-analytic review of studies investigating the effect of the anesthesia modality on perioperative mortality in endovascular repair of ruptured abdominal aortic aneurysms (REVAR). METHODS: The present meta-analysis was performed in accordance with the PRISMA guidelines. Multiple electronic databases were comprehensively searched from database inception to January 2020. Eligible studies included cohort studies that reported the 30-day/in-hospital mortality rate or the multivariate adjusted odds ratio (OR) or hazard ratio of the mortality risk for patients who underwent emergency REVAR under locoregional anesthesia (LA) vs general anesthesia (GA). A random effects model was used to estimate the ORs by pooling the related data from individual studies. RESULTS: A total of eight studies were included in this analysis. The first meta-analysis of seven studies that reported the 30-day/in-hospital mortality with a total of 3116 patients (867 in the LA group and 2249 in the GA group) revealed that LA was associated with a lower 30-day/in-hospital mortality than GA (16.4% vs 25.4%; unadjusted OR, 0.47; 95% confidence interval [CI], 0.32-0.68). The second meta-analysis of three of these seven studies (including 586 patients in the LA group and 1945 in the GA group) that reported the perioperative variables revealed comparable baseline characteristics but a lower 30-day/in-hospital mortality in the LA group (unadjusted OR, 0.55; 95% CI, 0.42-0.71). The third meta-analysis of the adjusted ORs or hazard ratios that were reported from four studies (including 501 patients in the LA group and 1136 in the GA group) showed a similar trend (adjusted OR,0.37; 95% CI, 0.19-0.75). CONCLUSIONS: REVAR under LA is associated with a lower 30-day/in-hospital mortality than REVAR under GA. However, because the included studies may have had some observation bias, further randomized controlled trials are warranted to validate the present results.
引用
- Deng J, Liu J, Rong D, et al. A meta-analysis of locoregional anesthesia versus general anesthesia in endovascular repair of ruptured abdominal aortic aneurysm. J Vasc Surg. 2020. PMID: 32882348. doi:10.1016/j.jvs.2020.08.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。